(Q54409514)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870429%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870429%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

0 references

0 references

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870429%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Jörg Ellinger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870429%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

David C Müller

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870429%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Stefan C Müller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870429%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Stefan Hauser

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870429%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Alexander von Ruecker

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870429%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Patrick J Bastian

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870429%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Gisela Walgenbach-Brunagel

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870429%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

26 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870429%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870429%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870429%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870429%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

509-515

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870429%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Tumor markers in the diagnosis of primary bladder cancer. A systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Screening for Prostate Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: a prognostic entity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Prediction of breast tumor progression by integrity of free circulating DNA in serum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Quantitative analysis of circulating mitochondrial DNA in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Plasma mitochondrial DNA concentrations after trauma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Circulating mitochondrial nucleic acids have prognostic value for survival in patients with advanced prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Mitochondrial DNA in serum of patients with prostate cancer: a predictor of biochemical recurrence after prostatectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Decrease of mitochondrial DNA content and energy metabolism in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: a quantitative study using laser-captured microdissected tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Prediction of clear cell renal cell carcinoma by integrity of cell-free DNA in serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Cell-free DNA: measurement in various carcinomas and establishment of normal reference range

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Is the quantity of circulatory cell-free DNA in human plasma and serum samples associated with gender, age and frequency of blood donations?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Circulating cell-free DNA in plasma of locally advanced rectal cancer patients undergoing preoperative chemoradiation: a potential diagnostic tool for therapy monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Increase in and clearance of cell-free plasma DNA in hemodialysis quantified by real-time PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Cell-free DNA levels as a prognostic marker in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Higher amount of free circulating DNA in serum than in plasma is not mainly caused by contaminated extraneous DNA during separation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Effects of preanalytical factors on the molecular size of cell-free DNA in blood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004

Quantification of mitochondrial DNA copy number: pre-analytical factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.004